Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Colorectal Neoplasms 18Neoplasms 6Rectal Neoplasms 4Colonic Neoplasms 4Neoplasm Metastasis 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Tongue Neoplasms 1Pancreatic Neoplasms 1Oesophago-gastric Cancer 1Esophageal Squamous Cell Carcinoma 1Colorectal Cancer Metastatic 1

Interventions

Cisplatin 47Radiotherapy 37Fluorouracil 23Cetuximab 17pembrolizumab 11Carboplatin 11Paclitaxel 8Docetaxel 8Radiotherapy, Intensity-Modulated 6Chemotherapy, Adjuvant 6Surgical Procedures, Operative 5Standard of Care 5nimotuzumab 4Methotrexate 4Gabapentin 4Drug Therapy 4Afatinib 4Radiotherapy, Conformal 3Radiation 3Porfiromycin 3Nivolumab 3Neoadjuvant Therapy 3Fibroblast Growth Factor 7 3Bleomycin 3zalutumumab 2sargramostim 2epacadostat 2Tranexamic Acid 2Tirapazamine 2Pilocarpine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Head and Neck Neoplasms × Panitumumab × Clear all
NCT00820248 2023-08-22

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

Canadian Cancer Trials Group

Phase 3 Completed
320 enrolled 13 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡